Medical evacuations among offshore oil and gas industries in the Gulf of Thailand.


Journal

International maritime health
ISSN: 2081-3252
Titre abrégé: Int Marit Health
Pays: Poland
ID NLM: 100958373

Informations de publication

Date de publication:
2020
Historique:
received: 08 03 2020
accepted: 27 03 2020
entrez: 1 7 2020
pubmed: 1 7 2020
medline: 15 12 2020
Statut: ppublish

Résumé

Medical evacuation in the offshore oil and gas industry is costly and risky. Previous studies have found that the main cause of medical evacuation due to illness is increasing. In Thailand, there have been no studies on the causes and costs of medical evacuation in the offshore oil and gas industry. This study aims to study on the causes and costs of medical evacuation among offshore oil and gas industry in the Gulf of Thailand. A retrospective review of data of medical evacuation among the offshore oil and gas industry in the Gulf of Thailand from 2016 to 2019 for a period of 36 months. During the research period, a total of 416 cases were evacuated. The majority of the causes of Medevac (84.13%) were illness. We found that 60.1% of all Medevacs were unpreventable or difficult to prevent, and only 39.9% were preventable. The cost of Medevac ranged from 10,000 to 880,000 THB per case. The cost of Medevac occurring from preventable causes was 17,160,000 THB for this period of 36 months. Reducing the cost of Medevac can be done by: 1) vaccination to prevent vaccine-preventable diseases, 2) screening to prevent people at risk of getting complications from pre-existing diseases to work offshore, and 3) increasing treatment capability of offshore facilities. Offshore oil and gas industry may consider cost-benefit of these approaches compared to status quo.

Sections du résumé

BACKGROUND
Medical evacuation in the offshore oil and gas industry is costly and risky. Previous studies have found that the main cause of medical evacuation due to illness is increasing. In Thailand, there have been no studies on the causes and costs of medical evacuation in the offshore oil and gas industry. This study aims to study on the causes and costs of medical evacuation among offshore oil and gas industry in the Gulf of Thailand.
MATERIALS AND METHODS
A retrospective review of data of medical evacuation among the offshore oil and gas industry in the Gulf of Thailand from 2016 to 2019 for a period of 36 months.
RESULTS
During the research period, a total of 416 cases were evacuated. The majority of the causes of Medevac (84.13%) were illness. We found that 60.1% of all Medevacs were unpreventable or difficult to prevent, and only 39.9% were preventable. The cost of Medevac ranged from 10,000 to 880,000 THB per case. The cost of Medevac occurring from preventable causes was 17,160,000 THB for this period of 36 months.
CONCLUSIONS
Reducing the cost of Medevac can be done by: 1) vaccination to prevent vaccine-preventable diseases, 2) screening to prevent people at risk of getting complications from pre-existing diseases to work offshore, and 3) increasing treatment capability of offshore facilities. Offshore oil and gas industry may consider cost-benefit of these approaches compared to status quo.

Identifiants

pubmed: 32604455
pii: VM/OJS/J/67868
doi: 10.5603/IMH.2020.0021
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114-122

Auteurs

Thanawat Sae-Jia (T)

Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, 1873 Rama IV Road, Pathum Wan, 10330 Bangkok, Thailand. thanawatsj@gmail.com.
Maritime Medicine Residency Training Institute, Naval Medical Department, Royal Thai Navy, 504 Somdet Phra Chao Tak Sin Rd, Bukkhalo, Thon Buri, 10600 Bangkok, Thailand. thanawatsj@gmail.com.

Pornchai Sithisarankul (P)

Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, 1873 Rama IV Road, Pathum Wan, 10330 Bangkok, Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH